@jennifer-carroll Many thanks
F
Frances
@Frances
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Posts
-
Clinical Paper -
Clinical PaperIt is my understanding that a pharmaceutical manufacturer is responsible for the clinical papers that a Rep has access to i.e., in their bag or on their iPad. If nothing is being done to change or enhance the clinical paper in any way (to brand it as an example) then the clinical paper does not need to be sent to PAAB and the manufacturer takes responsibility for the papers that a Rep holds. Please confirm.